US Lawmakers Call on FDA to Investigate US Clinical Trials That Partner With Chinese Military

A bipartisan group of lawmakers is calling on the U.S. Food and Drug Administration (FDA) to ensure that American clinical trials that are run in conjunction with the Chinese military are not aiding the “genocide” of ethnic minorities by the Chinese regime or putting national security at risk. “The Chinese Communist Party (CCP) is engaged in genocide of the Uyghur population,” the lawmakers wrote in a letter to FDA Commissioner Robert Califf. Further, “The United States needs the FDA to take on a greater role in protecting U.S. national security interests,” the Aug. 19 letter reads. In the letter, Reps. John Moolenaar (R-Mich.) and Raja Krishnamoorthi (D-Ill.), chair and ranking member of the House Select Committee on the CCP, respectively; Rep. Anna Eshoo (D-Calif.), ranking member of the Health Subcommittee; and Rep. Neal Dunn (R-Fla.) requested answers and a potential investigation....